Ibukić A, Ramić S, Zovak M, et al. Expression and prognostic significance of PD-L1 and NY-ESO1 in gallbladder carcinoma. In Vivo. 2023;37:1828–37.

Article  PubMed  PubMed Central  Google Scholar 

Tran TB, Norton JA, Ethun CG, et al. Gallbladder cancer presenting with jaundice: uniformly fatal or still potentially curable? J Gastrointest Surg. 2017;21:1245–53.

Article  PubMed  PubMed Central  Google Scholar 

Nishio H, Ebata T, Yokoyama Y, et al. Gallbladder cancer involving the extrahepatic bile duct is worthy of resection. Ann Surg. 2011;253:953–60.

Article  PubMed  Google Scholar 

Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362:1273–81.

Article  CAS  PubMed  Google Scholar 

Mizusawa J, Morizane C, Okusaka T, et al. Randomized phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan clinical oncology group study (JCOG1113, FUGA-BT). Jpn J Clin Oncol. 2016;46:385–8.

Article  PubMed  PubMed Central  Google Scholar 

Ioka T, Kanai M, Kobayashi S, et al. Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA). J Hepatobiliary Pancreat Sci. 2023;30:102–10.

Article  PubMed  Google Scholar 

Oh DY, Ruth He A, Qin S, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid. 2022;1:EVIDoa2200015.

Article  PubMed  Google Scholar 

Matsuyama R, Yabusita Y, Homma Y, et al. Essential updates 2019/2020: surgical treatment of gallbladder cancer. Ann Gastroenterol Surg. 2021;5:152–61.

Article  PubMed  PubMed Central  Google Scholar 

Bhatti ABH, Dar FS, Riyaz S, et al. Survival after extended resections for gallbladder cancer. Ann Hepatobiliary Pancreat Surg. 2023;27:70–5.

Article  PubMed  Google Scholar 

Yamamoto Y, Sugiura T, Ashida R, et al. Indications for major hepatectomy and combined procedures for advanced gallbladder cancer. Br J Surg. 2017;104:257–66.

Article  CAS  PubMed  Google Scholar 

Nakamura I, Hatano E, Baba H, et al. Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer. Ann Gastroenterol Surg. 2023;7:1009–20.

Article  PubMed  PubMed Central  Google Scholar 

Liu C, Fang F, Kong Y, et al. Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring. Diagn Pathol. 2023;18:48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang S, Nie J, Tai S, et al. PD-L1 inhibitor plus gemcitabine and cisplatin therapy followed by conversion surgery for initially unresectable advanced gallbladder cancer. BMJ Case Rep. 2023;16:e255403.

Article  PubMed  Google Scholar 

Prieto M, Gastaca M, Ruiz P, et al. Long term recurrence free survival in a stage IV gallbladder cancer treated with chemotherapy plus trastuzumab and salvage liver resection. Ann Hepatobiliary Pancreat Surg. 2019;23:403–7.

Article  PubMed  PubMed Central  Google Scholar 

Oh MY, Kim H, Choi YJ, et al. Conversion surgery for initially unresectable extrahepatic biliary tract cancer. Ann Hepatobiliary Pancreat Surg. 2021;25:349–57.

Article  PubMed  PubMed Central  Google Scholar 

Wakasa Y, Toyoki Y, Kusumi T, et al. Conversion surgery following gemcitabine plus cisplatin therapy for initially unresectable gallbladder cancer with peritoneal carcinomatosis: a case report. Surg Case Rep. 2022;8:50.

Article  PubMed  PubMed Central  Google Scholar 

Inoue M, Hakoda K, Sawada H, et al. Locally advanced gallbladder cancer treated with effective chemotherapy and subsequent curative resection: a case report. J Med Case Rep. 2022;16:30.

Article  PubMed  PubMed Central  Google Scholar 

Miura Y, Ashida R, Sugiura T, et al. Pathological complete response achieved by gemcitabine plus cisplatin therapy for initially unresectable advanced gallbladder cancer: a case report. Surg Case Rep. 2022;8:20.

Article  PubMed  PubMed Central  Google Scholar 

Al Jaber F, Almaher E, Al-Ibrahim R, et al. Curative surgical resection for initially unresectable metastatic gallbladder cancer following neoadjuvant chemotherapy: case report and review of literature. Int J Surg Case Rep. 2022;100:107694.

Article  PubMed  PubMed Central  Google Scholar 

Yang Z, Wu Z, Xiong Y, et al. Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy. Front Oncol. 2022;12:977963.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Takagi C, Sato M, Tomita M, et al. Induction chemotherapy and hepatic artery embolization followed by extended resection for locally advanced gallbladder cancer: a case report. Surg Case Rep. 2023;9:79.

Article  PubMed  PubMed Central  Google Scholar 

Hamad A, Aquina CT, Ansari A, et al. Impact of delay in adjuvant therapy for gallbladder adenocarcinoma. J Hepatobiliary Pancreat Sci. 2023;30:212–20.

Article  PubMed  Google Scholar